ConductScience.org, home

Paper19852033

Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.

Wang XS and 7 others. Cancer, 2010. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Papers, record 19852033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19852033

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.
PubMed
Journal
Cancer
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.03
iCite
Revised in PubMed
2025-05-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XSXin Shelley
2Shi QQiuling
3Lu CCharles
4Basch EMEthan M
5Johnson VEValen E
6Mendoza TRTito R
7Mobley GMGary M
8Cleeland CSCharles S

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Dyspnea
Fatigue
Female
Humans
Male
Middle Aged
Pain
Prognosis
Prospective Studies
Sleep Wake Disorders

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA026582NCI NIH HHSUnited StatesR01CA026582PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19587123Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study.Cancer1998https://conductscience.org/library/papers/9587123PubMed
211013380Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.Cancer2000https://conductscience.org/library/papers/11013380PubMed
39817289Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer.J Clin Oncol1998https://conductscience.org/library/papers/9817289PubMed
418227528The prognostic significance of patient-reported outcomes in cancer clinical trials.J Clin Oncol2008https://conductscience.org/library/papers/18227528PubMed
512911290The role of chemotherapy in the treatment of unresectable stage III and IV nonsmall cell lung cancer.Respir Care Clin N Am2003https://conductscience.org/library/papers/12911290PubMed
67561224Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer.J Pain Symptom Manage1995https://conductscience.org/library/papers/7561224PubMed
712697878
Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
J Clin Oncol2003https://conductscience.org/library/papers/12697878PubMed
811195407NCCN Practice Guidelines for Cancer Pain.Oncology (Williston Park)2000https://conductscience.org/library/papers/11195407PubMed
917951226Symptom burden: multiple symptoms and their impact as patient-reported outcomes.J Natl Cancer Inst Monogr2007https://conductscience.org/library/papers/17951226PubMed
1018048819Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.J Clin Oncol2007https://conductscience.org/library/papers/18048819PubMed
117659438When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.Pain1995https://conductscience.org/library/papers/7659438PubMed
1212719681Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.Med Care2003https://conductscience.org/library/papers/12719681PubMed
1316787687Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.Lung Cancer2006https://conductscience.org/library/papers/16787687PubMed
1415698531Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy.Lung Cancer2004https://conductscience.org/library/papers/15698531PubMed
1518241000Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer.Future Oncol2008https://conductscience.org/library/papers/18241000PubMed
1617568038ERCC1 and non-small-cell lung cancer.N Engl J Med2007https://conductscience.org/library/papers/17568038PubMed
177165009Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol1982https://conductscience.org/library/papers/7165009PubMed
1810091805The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.Cancer1999https://conductscience.org/library/papers/10091805PubMed
1910699541Symptoms in adults with lung cancer. A systematic research review.J Pain Symptom Manage2000https://conductscience.org/library/papers/10699541PubMed
2018158231Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?J Pain Symptom Manage2008https://conductscience.org/library/papers/18158231PubMed

See all 28 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42720799
Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study.
Support Care Cancer2026https://conductscience.org/library/papers/42720799PubMed
42036773Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial.Cancer Med2026https://conductscience.org/library/papers/42036773PubMed
41834268Non-Pharmacological Interventions for Cough in Patients With Lung Cancer: A Systematic Review and Meta-Analysis.J Clin Nurs2026https://conductscience.org/library/papers/41834268PubMed
41411039A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and Validation.JMIR Med Inform2025https://conductscience.org/library/papers/41411039PubMed
40042631Shared decision making in routine oncology appointments with Black patients with lung cancer.Support Care Cancer2025https://conductscience.org/library/papers/40042631PubMed
39862291Sleep quality in lung cancer and specifically non-small-cell lung cancer: a rapid review.Support Care Cancer2025https://conductscience.org/library/papers/39862291PubMed
39644035Patient-reported outcomes after CAR T-cell therapy in patients with hematological malignancies.Hematology Am Soc Hematol Educ Program2024https://conductscience.org/library/papers/39644035PubMed
39281186Clinicians' Prediction of Survival Is Most Useful for Palliative Care Referral.Palliat Med Rep2024https://conductscience.org/library/papers/39281186PubMed
39256698Prognosis and risk factor assessment of patients with advanced lung cancer with low socioeconomic status: model development and validation.BMC Cancer2024https://conductscience.org/library/papers/39256698PubMed
39199563Physical Deconditioning in Lung Cancer Patients Who Underwent Lung Resection Surgery in Spain: A Prospective Observational Study.Cancers (Basel)2024https://conductscience.org/library/papers/39199563PubMed
39177095Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings.Oncologist2025https://conductscience.org/library/papers/39177095PubMed
37208661
Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study.
BMC Pulm Med2023https://conductscience.org/library/papers/37208661PubMed
36625510Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.J Natl Cancer Inst2023https://conductscience.org/library/papers/36625510PubMed
36564827Symptom clusters and impact on quality of life in esophageal cancer patients.Health Qual Life Outcomes2022https://conductscience.org/library/papers/36564827PubMed
36533434Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US.Cancer Med2023https://conductscience.org/library/papers/36533434PubMed
36406000Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189.JTO Clin Res Rep2022https://conductscience.org/library/papers/36406000PubMed
33310772Strategies for improving the management of immune-related adverse events.J Immunother Cancer2020https://conductscience.org/library/papers/33310772PubMed
33163391Distinct Subgroups of Patients With Lung Cancer Receiving Chemotherapy: A Latent Transition Analysis.Front Oncol2020https://conductscience.org/library/papers/33163391PubMed
33010094
Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study.
Oncologist2020https://conductscience.org/library/papers/33010094PubMed
32374469Symptom burden trajectories experienced by patients with brain tumors.Cancer2020https://conductscience.org/library/papers/32374469PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19852033

GET https://conductscience.org/api/papers/v1/19852033/references?page=2